Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement 2024-10-29 20:30
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine 2024-10-25 20:30
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance 2024-10-08 20:30
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation 2024-09-27 19:00
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 2024-09-10 20:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 2024-08-15 20:30
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition 2024-07-05 19:00
1